Skip Ribbon Commands
Skip to main content
Menu
Dr Tan Shu Qi

Dr Tan Shu Qi

MBBS, MRCOG (UK)

Consultant

KK Women's and Children's Hospital

Specialty: General Obstetrics and Gynaecology, Obstetrics & Gynaecology

Clinical Appointments

  • Consultant Reproductive Medicine KK Women's and Children's HospitalKK Women's and Children's Hospital

Profile

Dr Tan Shu Qi obtained her undergraduate medical degree at St George’s, University of London, and is a member of the Royal College of Obstetricians and Gynaecologist in London. She is passionate about delivering babies and supporting her patients through their pregnancy journey, as well as helping women with their gynaecological problems. She is subspecialising in urogynaecology to help women with issues like prolapse and urinary incontinence. With a keen interest in research, she has attended many international conferences and published extensively.

Education

  • MRCOG (UK)
  • MBBS (UK)

Professional Appointments and Committee Memberships

  • Physician Faculty Member for Obstetrics & Gynecology Residency Program
  • Physician Faulty Member for PGY1 Residency Programme
  • Joint appointment in Duke-NUS medical school with Singapore Health Services Pte Ltd – Adjunct Research Fellow
  • Clinical Faculty Scheme appointment as Clinical Lecturer
  • Consultant, Department of Urogynaecology, KK Women’s and Children’s Hospital, Oct 2017 – Present
  • Academic Clinical Quality and Patient Safety Committee (Supervision)– Mar 2017 to Dec 2018
  • KKH Junior Officers Committee, Vice Chairman – 2018-2019

Awards

  • Outstanding Faculty Award 2019
  • SingHealth Best Resident Award 2012

Research Interests

  • Pregnancy related

Publications

  • Knowledge, perception and maternal immunisation practices of Tetanus-Diptheria-Acellular Pertussis (Tdap) and influenza vaccines amongst obstetricians in Singapore, S Thain, Tan SQ, S Tagore, Singapore Medical Journal, accepted for publication Feb 2019
  • Knowledge of pelvic floor disorder in pregnancy, JY Liu, SQ Tan, HC Han, International Urogynaecology Journal, 2019, 30:991-1001.
  • Lifestyle behaviours in women undergoing in vitro fertilization (IVF) in Singapore: a cross sectional survey, Tan SQ, Huang EY, Lau MSK, Viardot V, Teo S, Chan J, Tan HH, Nadarajah S, Women’s Health & Gynaecology, 2016; 2: 1.
  • Kotter’s Eight-Step Change Model: One Centre’s Experience for Transition to the GnRH Antagonist Protocol, SQ Tan, WW Lim, SL Liu, WLJ Phoon, Viardot V, J Chan, S Nadarajah, HH Tan, Journal of Women’s Health, Issues & Care, 2016; 5:5
  • Case report: Atypical Presentation of recurrent uterine fundal rupture diagnosed by ultrasound, SQ Tan, EWH Thia, CS Tee, GSH Yeo, Singapore Medical Journal, 2015; 56:e100-1.
  • Candida glabrata sepsis associated with chorioamnionitis in an IVF twin pregnancy: should we deliver? SQ Tan, OT Ng, CC Khong, Journal of Obstetrics and Gynaecology Research, 2015; 41: 962-6. doi: 10.1111/jog.12656. [Epub 2014 Dec 2014]
  • A pilot study of 2-octyl cyanoacrylate (DermabondTM)versus conventional suture skin closures for Caesarean Sections, SQ Tan, R Malhotra, JC Allen, TC Tan, Proceedings of Singapore Healthcare, 2014; 23:312-5.
  • Challenges in the management of a rare case of extensive retroperitoneal haemangioma in a pregnant woman, Tan SQ, Lim JSK, Tan YK, Tan HK, Singapore Medical Journal, 2014; 55:e177-9.
  • Reducing unnecessary antibiotic use in elective Caesarean sections: A Resident-led clinical quality improvement project, Tan SQ, L Koe, JJ Jung, M Lim, TX Ee, KH Tan, Singapore Journal of Obstetrics and Gynaecology, 2014; 45: 15-22.
  • Social Oocyte Freezing: A survey among Singapore female medical students, Tan SQ, Tan WK, Lau MSK, Tan HH, Nadarajah S, Journal of Obstetrics and Gynaecology Research, 2014; 40: 1345-52.
  • A cross-sectional pregnancy survey on fertility trends and pregnancy knowledge in Singapore, Tan TC, Tan SQ, Wei X, Journal of Obstetrics and Gynaecology Research, 2011; 37:992-6.
  • Characterisation of liver pathogenesis, human immune responses and drug testing in a humanized mouse model of HCV infection, Keng CT, Sze CW, Zheng D, Zheng Z, Yong KSM, Tan SQ, Ong JJY, Tan SY, Loh E, Upadya MH, Kuick CH, Hotta H, Lim SG, Tan TC, Chang KTE, Hong WJ, Chen JZ, Gut, 07/2015, DOI:10.1136/gutjnl-2014-307856.
  • Human CD34loCD133lo fetal liver cells support the expansion of human CD34hiCD133bj hematopoietic stem cells, Yong KSM, Keng CT, Tan SQ, Loh E, Change KTE, Tan TC, Hong WJ, Chen QF, Cellular & molecular immunology, 05/2015, DOI:10.1038/cmi.2015.43.
  • Human natural killer cells control Plasmodium falciparum infection by eliminating infected red blood cells, Chen QF, Amaladoss A, Ye WJ, Liu M, Dummler S, Kong F, Wong HL, Loo HL, Loh E, Tan SQ, Tan TC, Chang KTE, Dao M, Suresh S, Preiser PR, Chen JZ, Proceedings of the National Academy of Sciences of the United States of America, 2014; 111 (4): 1479-84.
  • Induction of functional human macrophages from bone marrow promonocytes by M-CSF in humanized mice, Li X, Chen QF, Zheng DH, Yin L, Chionh YH, Wong LH, Tan SQ, Tan TC, Chan JKY, Alonso S, Dedon PC, Lim B, Chen JZ, Journal of Immunology, 2013; 191: 3192-9. Prepublished online 9 Aug 2013

Research Trials